Gynecomastia with sulpiride

Journal of Clinical Pharmacy and Therapeutics

Volumn 27, Issue 1, 2002, Pages 75-77

  Kaneda, Y ^a,b   Fujii, A ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Department of Surgery   (Japan)

Author keywords

Estradiol; Gonadotropins; Gynecomastia; Prolactin; Sulpiride; Testosterone

Indexed keywords

BENZAMIDE; ESTRADIOL; PROLACTIN; SULPIRIDE; TESTOSTERONE;

ADULT; ANXIETY NEUROSIS; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; GALACTORRHEA; GYNECOMASTIA; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; PHYSICIAN; PRIMARY MEDICAL CARE;

ADMINISTRATION, ORAL; ADULT; ANTIPSYCHOTIC AGENTS; ANXIETY DISORDERS; ESTRADIOL; GYNECOMASTIA; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PROLACTIN; SULPIRIDE; TESTOSTERONE;

EID: 0036183769     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2002.00378.x     Document Type: Article

References (11)

1. Gynecomastia
2. Gynecomastia as a physical finding in normal men
3. Drug-induced gynecomastia
4. Demonstration of hormonal sensitivity in gynaecomastic tissue by thymidine incorporation in vitro
5. Sulpiride: An antipsychotic with selective dopaminergic antagonist properties
6. Prolactin and schizophrenia
7. Preclinical pharmacology of neuroleptics: Focus on new generation compounds
8. Serum prolactin levels in patients with gynecomastia
9. Hyperprolactinaemia and impotence
10. Re-evaluation of the role of catecholamines in control of gonadotropin and prolactin release
11. Effects of dopamine infusion on pituitary hormone secretion in humans